ICD-10 Coding for Angiosarcoma(C44.5, C44.5M, C44.5N)
Explore detailed ICD-10 coding for angiosarcoma, including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Angiosarcoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C49.9 | Malignant neoplasm of connective and soft tissue, unspecified | Use when angiosarcoma is confirmed in soft tissue without a specified site. |
|
| C44.5 | Malignant neoplasm of skin | Use for angiosarcoma primarily affecting the skin. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAngiosarcoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Angiosarcoma.
Failure to document metastasis
Impact
Clinical: Inaccurate treatment planning., Regulatory: Non-compliance with documentation standards., Financial: Potential loss of reimbursement for metastatic treatment.
Mitigation
Ensure all metastatic sites are documented.
Misclassification of angiosarcoma location
Impact
Reimbursement: Incorrect site coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data for epidemiological studies.
Mitigation
Verify the primary site of the tumor before coding.
Site-specific coding
Impact
Incorrect site coding can lead to audit flags.
Mitigation
Verify site with imaging and pathology before coding.